Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Colorization of H&E stained tissue using Deep Learning.

Samsi S, Jones M, Kepner J, Reuther A.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:640-643. doi: 10.1109/EMBC.2018.8512419.

PMID:
30440478
2.

In-Vitro Pulsatile Flow Measurement in Prosthetic Heart Valves: An Inter-Laboratory Comparison.

Retta SM, Kepner J, Marquez S, Herman BA, S Shu MC, Grossman LW.

J Heart Valve Dis. 2017 Jan;26(1):72-80.

PMID:
28544834
3.

Specificity of genome evolution in experimental populations of Escherichia coli evolved at different temperatures.

Deatherage DE, Kepner JL, Bennett AF, Lenski RE, Barrick JE.

Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):E1904-E1912. doi: 10.1073/pnas.1616132114. Epub 2017 Feb 15.

4.

Resilience of Cyber Systems with Over- and Underregulation.

Gisladottir V, Ganin AA, Keisler JM, Kepner J, Linkov I.

Risk Anal. 2017 Sep;37(9):1644-1651. doi: 10.1111/risa.12729. Epub 2016 Dec 9.

PMID:
27935146
5.

The differences between yoga teacher training and yoga therapist training and the distinction between yoga teaching and yoga therapy.

Kepner J, Devi NJ, Le Page J, Le Page L, Kraftsow G, Lee M.

Int J Yoga Therap. 2014;24:7-21.

PMID:
25858647
6.

A biomedical engineering approach to mitigate the errors of prostate biopsy.

Ahmed HU, Emberton M, Kepner G, Kepner J.

Nat Rev Urol. 2012 Feb 7;9(4):227-31. doi: 10.1038/nrurol.2012.3. Review.

PMID:
22310216
7.

Outcomes of a cancer clinical trial matching service.

Gansler T, Jin M, Bauer J, Dahlquist K, Tis L, Sharpe K, Comis R, Naples K, Kepner J.

J Cancer Educ. 2012 Mar;27(1):11-20. doi: 10.1007/s13187-011-0296-x.

PMID:
22131066
8.

Statistical modeling of lung cancer: answering relative questions.

Cong C, Kepner J, Tsokos CP.

Int J Biomed Sci. 2011 Mar;7(1):70-6.

9.
10.

Theory-based evaluation of an online cancer fatigue class.

Smith T, Richardson K, Crammer C, Greer G, Stein KD, Mehta CC, Kepner JL.

J Cancer Educ. 2010 Sep;25(3):422-30. doi: 10.1007/s13187-010-0067-0.

PMID:
20383672
11.

Use of a liquid nicotine delivery product to promote smoking cessation.

Geimer N, Olson CE, Baumgarten D, Kepner JL, Mahoney MC.

BMC Public Health. 2010 Mar 24;10:155. doi: 10.1186/1471-2458-10-155.

12.

Evolving information priorities of hematologic cancer survivors, caregivers, and other relatives.

Gansler T, Kepner J, Willacy E, Soloe C, Rupert D, Jarblum M, Driscoll D, Orr A, Fitzgerald T, Esparza A.

J Cancer Educ. 2010 Sep;25(3):302-11. doi: 10.1007/s13187-009-0034-9.

PMID:
20119694
13.

On group sequential designs comparing two binomial proportions.

Kepner JL.

J Biopharm Stat. 2010 Jan;20(1):145-59. doi: 10.1080/10543400903280621.

PMID:
20077254
14.

Exact tests using two correlated binomial variables in contemporary cancer clinical trials.

Yu J, Kepner JL, Iyer R.

Biom J. 2009 Dec;51(6):899-914. doi: 10.1002/bimj.200900082.

PMID:
20014199
15.

Photopheresis in HIV-1 infected patients utilizing benzoporphyrin derivative (BPD) verteporfin and light.

Bernstein ZP, Dougherty T, Gollnick S, Schwartz SA, Mahajan SD, Kepner J, Sumlin A, Stewart C, Wallace P, Adal A, Walder H, Poiesz B.

Curr HIV Res. 2008 Mar;6(2):152-63.

PMID:
18336263
16.

An evaluation of the American Cancer Society research scholar program.

Tucker AL, Vogler WR, Kepner JL.

J Cancer Educ. 2007 Fall;22(3):165-7.

PMID:
17760522
17.

A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study.

Iyer RV, Gibbs J, Kuvshinoff B, Fakih M, Kepner J, Soehnlein N, Lawrence D, Javle MM.

Ann Surg Oncol. 2007 Nov;14(11):3202-9. Epub 2007 Aug 19.

PMID:
17705089
18.

Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.

Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C.

Pediatr Blood Cancer. 2008 Feb;50(2):227-30.

PMID:
17278121
19.

The rationale, design, and implementation of the American Cancer Society's studies of cancer survivors.

Smith T, Stein KD, Mehta CC, Kaw C, Kepner JL, Buskirk T, Stafford J, Baker F.

Cancer. 2007 Jan 1;109(1):1-12.

20.

Changes in treatment of advanced laryngeal cancer 1985-2001.

Chen AY, Schrag N, Hao Y, Flanders WD, Kepner J, Stewart A, Ward E.

Otolaryngol Head Neck Surg. 2006 Dec;135(6):831-7.

PMID:
17141069
21.

Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.

Leichman L, Lawrence D, Leichman CG, Nava H, Nava E, Proulx G, Clark K, Khushalani NI, Berdzik J, Greco W, Smith P, Creaven PJ, Kepner JL, Javle MM, Pendyala L.

J Chemother. 2006 Oct;18(5):514-24.

PMID:
17127229
22.

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M, Livingston P, Iasonos A, Spriggs D, McGuire W, Reinartz S, Schneider S, Grande C, Lele S, Rodabaugh K, Kepner J, Ferrone S, Odunsi K.

Clin Cancer Res. 2006 Sep 15;12(18):5503-10.

23.

A Phase II study of St. John's Wort for smoking cessation.

Lawvere S, Mahoney MC, Cummings KM, Kepner JL, Hyland A, Lawrence DD, Murphy JM.

Complement Ther Med. 2006 Sep;14(3):175-84. Epub 2006 Jun 13.

PMID:
16911897
24.

Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031.

Miralbell R, Fitzgerald TJ, Laurie F, Kessel S, Glicksman A, Friedman HS, Urie M, Kepner JL, Zhou T, Chen Z, Barnes P, Kun L, Tarbell NJ.

Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1325-30. Epub 2006 Jan 18.

PMID:
16413699
25.

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43. Epub 2005 Dec 12.

26.

A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.

Chintagumpala MM, Friedman HS, Stewart CF, Kepner J, McLendon RE, Modrich PL, McCluggage C, Burger P, Holmes E, Thompson S, Rutka J, Michalski J, Woo S, Blaney SM, Kun LE, Horowitz ME; Pediatric Oncology Group Study.

J Neurooncol. 2006 Apr;77(2):193-8.

PMID:
16314955
27.

Review of tonsillar lymphoma in pediatric patients from the pediatric oncology group: what can be learned about some indications for microscopic examination?

Sayed K, Van Savell H Jr, Hutchison RE, Kepner J, Link MP, Schwenn M, Mahmoud H, Parham DM.

Pediatr Dev Pathol. 2005 Sep-Oct;8(5):533-40. Epub 2005 Oct 5.

PMID:
16211449
28.

Postoperative computed tomography scan surveillance for patients with stage II and III colorectal cancer: worthy of further study?

Mortazavi A, Shaukat A, Othman E, Kepner JL, Fakih MG, Kuvshinoff BW, Smith JL, Javle MM.

Am J Clin Oncol. 2005 Feb;28(1):30-5.

PMID:
15685032
29.
30.

Yoga research and Richard Freeman.

Kepner J.

Altern Ther Health Med. 2004 Jul-Aug;10(4):14. No abstract available.

PMID:
15285269
31.

Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?

Shaukat A, Mortazavi A, Demmy T, Nava H, Wilkinson N, Yang G, Kepner J, Javle M.

Dis Esophagus. 2004;17(2):129-35.

PMID:
15230725
32.

Samples of exact k-stage group sequential designs for Phase II and Pilot studies.

Kepner JL, Chang MN.

Control Clin Trials. 2004 Jun;25(3):326-33.

PMID:
15157732
33.

Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.

Aquino VM, Weitman SD, Winick NJ, Blaney S, Furman WL, Kepner JL, Bonate P, Krailo M, Qu W, Bernstein M.

J Clin Oncol. 2004 Apr 15;22(8):1413-9.

PMID:
15084615
34.

Sample sizes based on exact unconditional tests for phase II clinical trials with historical controls.

Chang MN, Shuster JJ, Kepner JL.

J Biopharm Stat. 2004 Feb;14(1):189-200.

PMID:
15027508
35.

The effectiveness of complete decongestive physiotherapy for the treatment of lymphedema following groin dissection for melanoma.

Hinrichs CS, Gibbs JF, Driscoll D, Kepner JL, Wilkinson NW, Edge SB, Fassl KA, Muir R, Kraybill WG.

J Surg Oncol. 2004 Mar 15;85(4):187-92.

PMID:
14991874
36.

Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237.

Dreyer ZE, Kadota RP, Stewart CF, Friedman HS, Mahoney DH, Kun LE, McCluggage CW, Burger PC, Kepner J, Heideman RL; Pediatric Oncology Group.

Neuro Oncol. 2003 Oct;5(4):261-7.

37.

MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.

Aldosari N, Bigner SH, Burger PC, Becker L, Kepner JL, Friedman HS, McLendon RE.

Arch Pathol Lab Med. 2002 May;126(5):540-4.

PMID:
11958658
38.

Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.

Eberhart CG, Kepner JL, Goldthwaite PT, Kun LE, Duffner PK, Friedman HS, Strother DR, Burger PC.

Cancer. 2002 Jan 15;94(2):552-60.

39.

Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group study.

Furman WL, Stewart CF, Kirstein M, Kepner JL, Bernstein ML, Kung F, Vietti TJ, Steuber CP, Becton DL, Baruchel S, Pratt C.

J Clin Oncol. 2002 Mar 15;20(6):1617-24.

PMID:
11896112
40.

Surveillance neuroimaging to detect relapse in childhood brain tumors: a Pediatric Oncology Group study.

Minn AY, Pollock BH, Garzarella L, Dahl GV, Kun LE, Ducore JM, Shibata A, Kepner J, Fisher PG.

J Clin Oncol. 2001 Nov 1;19(21):4135-40.

PMID:
11689581
41.

Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.

Saylors RL 3rd, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ; Pediatric Oncology Group.

J Clin Oncol. 2001 Aug 1;19(15):3463-9.

PMID:
11481351
42.

Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.

Hurwitz CA, Strauss LC, Kepner J, Kretschmar C, Harris MB, Friedman H, Kun L, Kadota R.

J Pediatr Hematol Oncol. 2001 Jun-Jul;23(5):277-81.

PMID:
11464982
43.

Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.

Mahoney DH Jr, Cohen ME, Friedman HS, Kepner JL, Gemer L, Langston JW, James HE, Duffner PK, Kun LE.

Neuro Oncol. 2000 Oct;2(4):213-20. doi: 10.1093/neuonc/2.4.213.

44.

"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.

Brown HG, Kepner JL, Perlman EJ, Friedman HS, Strother DR, Duffner PK, Kun LE, Goldthwaite PT, Burger PC.

J Neuropathol Exp Neurol. 2000 Oct;59(10):857-65.

PMID:
11079775
45.

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke L, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE.

J Clin Oncol. 2000 Aug;18(16):3004-11.

PMID:
10944134
46.

A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?

Freeman CR, Kepner J, Kun LE, Sanford RA, Kadota R, Mandell L, Friedman H.

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):561-4.

PMID:
10837936
47.

Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.

Hutchison RE, Finch C, Kepner J, Fuller C, Bowman P, Link M, Schwenn M, Laver J, Desai S, Barrett D, Murphy SB.

Ann Oncol. 2000;11 Suppl 1:35-8.

PMID:
10707776
48.

Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome.

Tihan T, Fisher PG, Kepner JL, Godfraind C, McComb RD, Goldthwaite PT, Burger PC.

J Neuropathol Exp Neurol. 1999 Oct;58(10):1061-8.

PMID:
10515229
49.

Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.

Reardon DA, Entrekin RE, Sublett J, Ragsdale S, Li H, Boyett J, Kepner JL, Look AT.

Genes Chromosomes Cancer. 1999 Mar;24(3):230-7.

PMID:
10451703
50.

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study.

Kadota RP, Stewart CF, Horn M, Kuttesch JF Jr, Burger PC, Kepner JL, Kun LE, Friedman HS, Heideman RL.

J Neurooncol. 1999 May;43(1):43-7.

PMID:
10448870

Supplemental Content

Loading ...
Support Center